Epigenetic drug library screening reveals targeting DOT1L abrogates NAD+ synthesis by reprogramming H3K79 methylation in uveal melanoma
- Resource Type
- Article
- Source
- In
Journal of Pharmaceutical Analysis January 2023 13(1):24-38 - Subject
- Language
- ISSN
- 2095-1779